ArticlemedRxiv : the preprint server for health sciences2026

A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence.

Emily Bivens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.